In the case of the studies on pharmacological chaperones for PAH, it was found that the amount of immunoreactive PAH protein and PAH activity in eukaryote cells transiently expressing wild-type and mutant PAH increased at defined incubation times in the presence of the selected compounds [50, 51]. Here, PAH is linked to pulmonary arterial hypertension.